1. 1,2,4-Triglycidylurazol or TGU (NSC-332488): a new anti neoplastic agent;Atassi,1982
2. Phase I study of α-1,3,5-triglycidyl-s-triazinetrione (NSC-296934);Dombernowsky;Cancer Chemother Pharmacol,1983
3. Phase I trial of 1,3,5-triglycidyl-s-triazinetrione (TGT, NSC-296934);Cavalli,1981
4. Phase I trial of 1,2,4-Triglycidylurazol (TGU, NSC-332488) with a daily × 5 schedule;Rozencweig,1983